Bausch + Lomb Announces Presentation of New Scientific Data and Evaluations Featuring Consumer, Vision Care and Pharmaceutical Products at Optometry’s Meeting?

Business Wire
10 min read

In This Article:

15 ePosters and In-Person Presentations Will Include Clinical Data on Blink? NutriTears? Supplement for Dry Eyes, Blink? Triple Care Lubricating Eye Drops and MIEBO? (Perfluorohexyloctane Ophthalmic Solution)

VAUGHAN, Ontario, May 28, 2024--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the presentation of 12 ePosters during the American Optometric Association (AOA) Optometry’s Meeting ePoster Session, taking place virtually May 29-30, 2024. The company will also have three live presentations and host nine education events during the in-person meeting, taking place in Nashville June 19-22, 2024.

The OnDemand ePosters will feature new data on the early adoption of MIEBO and real-world patient experiences with Bausch + Lomb INFUSE? Multifocal silicone hydrogel daily disposable contact lenses. An evaluation of the performance of Biotrue? Hydration Plus Multi-Purpose Solution among two different patient demographics – soft contact lens wearers who are also frequent gamers and users planning to stop wearing lenses due to discomfort – will also be highlighted.

The live, in-person presentations will include clinical data evaluating Blink NutriTears clinically proven nutritional supplement for dry eyes*, which was selected by AOA as one of the top five Optometry’s Meeting abstracts. Two other presentations will showcase clinical evaluation data for Blink Triple Care Lubricating Eye Drops, the first and only over-the-counter eye drop with both hyaluronate and a nano-emulsion lipid in the unique formula.

The complete list of scientific ePosters and live presentations, as well as details for the featured education events, is as follows:

e-Poster Presentations

  • "A Multi-country Assessment of Satisfaction with a Spherical Silicone Hydrogel Daily Disposable Contact Lens Among New Contact Lens Wearers and Their Eyecare Professionals." Reindel et al.

  • "Comparison of Clinical Studies from the US and India of a Multi-Ingredient Oral Supplement." Gioia et al.

  • "Early Adoption and Utilization of Perfluorohexyloctane for Dry Eye Disease." Alexander et al.

  • "Evaluation of the Efficacy of a Novel Preservative-Free Formulation of Brimonidine Tartrate Ophthalmic Solution." Evans et al.

  • "Evaluation of the Safety of a Novel Preservative-Free Formulation of Brimonidine Tartrate Ophthalmic Solution." Evans et al.

  • "Frequent Gamers Tag a Novel Contact Lens Solution with High Satisfaction" Shahidi et al.

  • "Improvement in Non-Invasive Tear Break-Up Time after Instillation of One Drop of Brimonidine Tartrate 0.025%." Moore et al.

  • "Ocular Vasoconstrictors: Does Mechanism of Action Make a Difference?" Moore et al.

  • "On the Verge of Dropout: An In-Home Use Test of a Novel Contact Lens Solution Among Planned Replacement Contact Lens Wearers." Shahidi et al.

  • "Patient Performance Assessment with Multifocal Toric Silicone Hydrogel Contact Lenses." Rah et al.

  • "Patient-reported Instillation Comfort and Eyedrop Acceptability of Perfluorohexyloctane Ophthalmic Solution in Pivotal Clinical Studies." Cunningham et al.

  • "Real-world Evaluation of a Daily Disposable Silicone Hydrogel Multifocal Contact Lens." Rah et al.

Recommended Stories